US 11518818
Therapeutic anti-IgE antibodies and methods and compositions thereof
granted A61KA61K2039/505A61P
Quick answer
US patent 11518818 (Therapeutic anti-IgE antibodies and methods and compositions thereof) held by The Regents of the University of California expires Mon Dec 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Dec 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K2039/505, A61P, A61P37/06, A61P37/08